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Certain autoimmune sera contain antibodies against a nucleolar ribonucleoprotein parti-
cle associated with 7-2-RNA (R. Reddy et al. (1983) J . Bioi. Chem . 258, 1383; C. 
Hashimoto and J. A. Steitz (1983) J. Bioi. Chem. 258, 1379). In this study, we showed by 
immunofluorescence microscopy that antibodies reactive with 7-2-ribonucleoprotein im-
munolocalized in the granular regions of actinomycin D and 5,6-dichloro-I-j3-D-ribofurano-
sylbenzimidazole (DRB)-segregated nucleoli from Vero cells. By electron microscopic 
immunocytochemistry, antigen-antibody complexes were located in the granular compo-
nent of transcriptionally active nucleoli from rat liver hepatocytes and HeLa cells. Anti-7-
2-RNP antibodies from two autoimmune sera immunoprecipitated a major protein of Mr 
40,000 from e5S] methionine-Iabeled HeLa cell extract. The immunolocalization data 
suggest that 7-2-ribonucleoprotein may be involved in stages of ribosome biogenesis which 
take place in the granular component of the nucleolus, i.e., assembly, maturation , and/or 
transport of preribosomes . © 1988 Academic Press , Inc. 
Patients with systemic autoimmune diseases frequently produce autoantibodies 
against a variety of nuclear and nucleolar proteins and RNA-protein complexes 
[3]. Recently, autoimmune sera were shown to be valuable tools in mapping the 
topology of nucleolar proteins (for review, see Ref. [4]). We showed that certain 
scleroderma antibodies stain the fibrillar centers of nucleoli and are directed 
against RNA polymerase I [5]. Other scleroderma sera contain antibodies against 
a basic (pI, 8.5) Mr 34,000 nucleolar protein ofthe U3-ribonucleoprotein complex 
[6]. This protein was located in the fibrillar component of nucleoli [7] and hence 
named fibrillarin. Since various stages of ribosome biogenesis in eukaryotes are 
believed to take place in morphologically defined regions of nucleoli (for review 
see Ref. [8]), immunolocalization of any nucleolar protein should provide impor-
tant leads for understanding the functional organization of the nucleolus. 
In this study autoantibodies against 7-2-ribonucleoprotein were located within 
the granular component of nucleoli. This specific localization indicates that 7-2-
ribonucleoprotein may be involved in preribosome assembly, maturation, and/or 
I This is publication number 4789 BCR of the Department of Basic and Clinical Research, Scripps 
Clinic and Research Foundation, La Jolla, California 92037. This work was supported by NIH Grant 
AM32063 . G. Reimer was supported by a grant of the Deutsche Forschungsgemeinschaft. 
2 To whom reprint requests should be addressed at Scripps Clinic and Research Foundation, 10666 
North Torrey Pines Road , La Jolla , CA 92037. 
3 Abbreviations used: PBS, phosphate-buffered saline; RNP, ribonucleoprotein; DRB, 5,6-di-
chloro-I-j3-D-ribofuranosylbenzimidazole; mol wt, molecular weight. 
117 Copyright © 1988 by Academic Press, Inc. 
AU rights of reproduction in any form reserved 
0014·4827/88 $03.00 
118 Reimer et al. 
transport, biological stages of ribosome biogenesis that have been mapped to the 
granular component of the nucleolus (for review, see Ref. [8]). Identification and 
characterization of autoantigens may also be important steps in the elucidation of 
the nature of autoimmune responses in defined disease entities. 
MATERIAL AND METHODS 
Antibodies. Reference antibodies To against 7-2-ribonucleoprotein were from the same serum as that 
used by Reddy et al. [1]. Serum Wa was from a 48-year-old female patient with a 6-year history of 
relapsing arthritis/arthralgias, moderate lymphocytopenia, fever, malaise, and severe Raynaud 's 
phenomenon without further clinical or laboratory findings which would allow definite classification 
of her connective tissue disease. Normal human serum and anti-SS-B/La serum were from the serum 
collection of the Autoimmune Disease Center, Scripps Clinic and Research Foundation , La Jolla , 
California. Monoclonal antibody 72B9 of the IgG2a isotype reactive with U3-RNP-associated fibril-
larin was derived from spleen cells of a NZB/NZW FI mouse by hybridoma technology [9]. 
Indirect immunofluorescence. Indirect immunofluorescence was performed with human HeLa 
cells, monkey Vero cells, marsupial rat kangaroo PtK2 cells, and fish FHM cells. The cells were 
obtained from the American Type Culture Collection (Rockville , MD). Cells were grown on micro-
scopic slides and fixed in acetone/methanol 3: 1 cooled to -20°C for 3 min. Other substrates were 
commercially available human Hep-2 cells (Bion, Park Ridge , IL) and rabbit kidney cells (Electronu-
c1eonics , Bethesda, MD). Autoimmune and control sera were diluted at I : 40 in phosphate-buffered 
saline (PBS)/ pH 7.4. As detecting reagents , a fluorescein-labeled (Behring Diagnostics, La Jolla, 
CA) and a rhodamine-labeled (Tago, Burlingame, CA) goat anti-human IgG conjugate were used. A 
fluorescein-labeled goat anti-mouse IgG conjugate was obtained from Tago . Intensity of immunofluo-
rescence staining was graded from weak (+), moderate (++), to st rong (+ + +). Results were read on 
a Leitz Ortholux 11 fluorescence microscope equipped with a Leitz Ploempak vertical illuminator 
using a NPL Fluortar 100/1.32 oil immersion objective. Double-label immunofluorescence was 
performed as described [10]. 
Drug studies. Segregation of nucleoli in tissue culture Vero cells into fibrillar and granular regions 
was induced by the addition 0.2 ~glml actinomycin D to the culture medium for 4 h or 50 ~glml 5,6-
dichloro-I-,B-o-ribofuranosylbenzimidazole , a halogenated adenosine analog, for 6 h. Both drugs were 
purchased from Behring Diagnostics. After drug treatment , cells were fixed in acetone/methanol 3: I 
and processed for indirect immunofluorescence as described above. 
Electron microscopic immunocytochemistry . For preembedding antibody labeling, frozen sections 
(5 ~m thickness) of rat liver were fixed in acetone at -20°C for 10 min , air dried , and incubated with 
normal control serum, scleroderma anti-RNA polymerase I , serum To, or serum Wa diluted I : 100 in 
PBS for 30 min. After several washes in PBS, goat IgG (I mglml in PBS) was added to the tissue 
sections for 5 min to block nonspecific binding sites followed by goat anti-human IgG coupled to 
colloidal gold (5 nm diameter , Janssen Life Sciences , Beerse, Belgium) diluted I : 20 in PBS and 
containing I mglml goat IgG. After 2 h incubation at 4°C, the specimens were fixed and processed for 
electron microscopy as described recently [11]. For postembedding antibody labeling, HeLa cells 
were fIXed for 2 h in 8% paraformaldehyde containing 0.2 M pipes buffer, pH 7.0. The cell pellet was 
infused with 2.1 M sucrose in PBS and frozen on cryospecimen pins. Ultrathin frozen sections were 
cut on a Reichert Ultracut microtome equipped with FC4 cryoattachment. Cryosections were 
incubated with To antibodies diluted I: 10 in PBS for I h. Secondary antibodies specific for human 
IgG coupled to lO-nm gold particles (Janssen Life Sciences) were used as the detecting reagent and 
the immunoreaction was visualized as described in detail elsewhere [12-13]. Grids with Formvar-car-
bon films were inspected in Opton 92S, Philips 301, and Jeol 1200 electron microscopes. 
Nuclease digestion . For nuclease digestion experiments, Vero cells grown on microscopic slides 
were digested with 0.25 mglml DNase I (Millipore , Freehold, NJ) in PBS containing 5 mM MgCI2, or 
with 0.25 mglml RNase A (Millipore) in PBS for 30 min at 37°C. Phenylmethylsulfonyl fluoride at 2 
mM was added to the digestion buffers to prevent proteolytic degradation. After digestion , cells were 
washed in PBS and further processed for indirect immunofluorescence as described . As controls, 
substrates were also preincubated in buffer without enzymes. To assess the effectiveness of nuclease 
digestion , monoclonal antibodies to native DNA [10] and RNA [14] were simultaneously incubated 
with nuclease-pretreated cells and processed by immunofluorescence. 
Immunoprecipitation . HeLa cells were cultured in monolayers and were radiolabeled for 20 h with 
elS]methionine and e 2P]orthophosphate (New England Nuclear, Boston, MA) . Cells were extracted 
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in buffer A containing 10 mM Tris-HCl (pH 7.4) , 150 mM NaCl , 1.5 mM MgCI2, 0.5 % Nonidet-P40 , 
supplemented with Kallikrein inactivator (Behring Diagnostics) as described [15] . Immunoprecipita-
tion of radiolabeled antigens was performed as described [5, 15] . In brief, serum aliquots were 
incubated with protein A-Sepharose CL-4B (Pharmacia, Uppsala, Sweden) at 10 % (v/v) suspended in 
buffer B (50 mM Tris-HCI (pH 7.4), 150 mM NaCl, 5 mM EDTA, 0.5 % sodium deoxycholate , and 
0.1 % sodium dodecyl sulfate (SDS». After washing in buffer B, radiolabeled HeLa cell proteins were 
added to the beads and incubated for I h with constant mixing. The beads were then washed in buffer 
B containing 23 U/m] Kallikrein inactivator and the proteins were detached from the beads by boiling 
in Laemmli sample buffer [16] . Antigen analysis was performed in 15 and 17.5% SDS-polyacrylamide 
gels followed by autoradiography. Half of the l2P-labeled pellet was phenol-extracted and any RNA 
was precipitated in ethanol. RNA analysis was performed in 7 M urea, 8% polyacrylamide gels . 
Antigen depletion experiments were performed as described [5]. eSS]methionine-labeled HeLa cell 
extract (50 ~g of protein) was preabsorbed with IgG (20 ~g) from serum To bound to protein 
A-Sepharose CL-4B for 45 min at 4°C. The supernatant was then used for immunoprecipitation with 
the same amount of IgG from serum Wa. In another experiment, eSS]methionine-labeled HeLa cell 
proteins were digested with RNase at 0.25 mg/m] and then preabsorbed with IgG from serum Wa. 
The absorbed supernatant was then used as antigen source in immunoprecipitation with serum To . 
RESULTS 
Indirect immunofluorescence. Autoimmune serum To produced bright homo-
geneous staining ( + + + ) of all nucleoli in Hep-2 cells, HeLa cells, and Vero cells. 
Weak (+) nucleoplasmic staining was also observed. Nucleolar staining (+ to 
+ +) was also present in rat kangaroo PtK2 and fish FHM cells. Figure 1 shows 
nucleolar staining by antibodies from serum To in HeLa cells (a) and Vero cells 
(c). For comparison, all cells are also shown in phase-contrast optics (b and d). 
For immunolocalization of autoantibodies from serum To in nucleolar subcom-
partments, Vero cells were exposed to the nucleolus-segregating drugs actino-
mycin D and DRB. Following drug treatment, cells were processed for indirect 
immunofluorescence. Actinomycin D-inactivated nucleoli show a typical segre-
gation of the fibrillar component from the granular component, resulting in the 
formation of distinct nucleolar hemispheres [17-19] as shown by phase-contrast 
microscopy in Fig. 2 a. The dark hemispheres (arrows) in (a) represent the 
granular regions. Antibodies from serum To were now detected in the granular 
regions with a rhodamine anti-human IgG conjugate (b). By contrast, mouse 
monoclonal antibody 72B9 against fibrillarin stained the fibrillar component (c) of 
the same segregated nucleoli as shown with a fluorescein anti-mouse IgG conju-
gate . When DRB was added to Vero cells growing in culture, the compact 
nucleoli of Vero cells unraveled into extended beaded strands again segregating 
the nucleolus into granular and fibrillar regions [20-22] . The phase dark granular 
regions in (d) are pointed out by arrows . Immunofluorescence staining of DRB-
pretreated Vero cells by antibodies from serum To was in the granular regions (e) 
whereas monoclonal antibody 72B9 stained the fibrillar regions of DRB-segregat-
ed nucleoli in a "necklace" distribution (j) . It should be noted that actinomycin D 
and DRB , in concentrations and incubation periods as used in this study, reduced 
staining of segregated nucleoli when compared with the staining intensity of 
untreated cells (for comparison see Fig. 1). 
Antibodies from serum Wa gave identical nucleolar immunofluorescence re-
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Fig. J. Staining patterns produced by antibodies from serum To reactive with 7-2-ribonucleoprotein 
in tissue culture HeLa and Yero cells . After incubation of the cells with serum To , antibody-antigen 
complexes were detected by a fluorescein anti-human IgG conjugate. Bright homogeneous nucleolar 
staining was present in all HeLa cells (a) and Yero cells. Weak granular nucleoplasmic staining was 
also produced by serum To. In Yero cells during late telophase (c) immunofluorescence was diffusely 
distributed in the reconstituting nuclei with little staining of reforming nucleolar structures. All cells 
are also shown in phase-contrast optics (b and dJ. Bars 10 Ilm , x 1450. 
suIts in untreated as well as actinomycin D- or DRB-treated Vero cells (not 
shown). 
Electron Microscopy. Electron microscopic immunocytochemistry was per-
formed using serum To, Wa, and different control sera in the pre- and postembed-
7-2-Ribonucleoprotein in the nucleolus 121 
Fig. 2. Drug studies. Tissue culture Yero cells were exposed to actinomycin D (a, b, and c) and 
DRB (d, e, and f> before processing for indirect immunofluorescence in the doublelabel technique. 
The granular component in actinomycin D (a) and DRB-segregated nucleoli (d) is the phase denser 
portion (arrows) of the segregated nucleoli . Antibodies from serum To predominantly stained the 
granular component of actinomycin D (b) and DRB-segregated nucleoli (e). As a control, the fibrillar 
component (c and f> was specifically stained by monoclonal antibody 72B9 against fibrillarin , a U3-
RNP-associated protein. Bars IO f.lm , x 1450. 
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ding immunogold label techniques. In these experiments, antibodies from serum 
To and Wa were localized in the granular component of nucleoli in rat liver 
hepatocytes and HeLa cells. Fig. 3 illustrates the results of the preembedding 
labeling technique and shows that IgG from serum To was selectively enriched 
over the granular component and virtually absent from the dense fibrillar compo-
nent or fibrillar centers. Using ultrathin frozen sections of He La cells and serum 
To for the postembedding labeling protocol, gold-antibody-antigen complexes 
were again localized predominantly over the granular component and essentially 
absent from the dense fibrillar component or fibrillar centers (Fig. 4). In the 
control experiments, scleroderma anti-RNA polymerase I antibodies were selec-
tively enriched over the fibrillar centers in both labeling techniques and virtually 
absent from the granular or dense fibrillar components (not shown, also see Refs. 
[4, 5, and 23]) . Thus, both labeJing techniques gave comparable results. 
Nuclease digestion studies. To evaluate the effect of nuclease digestion on the 
antigen recognized by antibodies from serum To and Wa, Vero cell substrates 
were preincubated with DNase and RNase. Neither of these nucleases substan-
tially altered intensity of nucleolar immunofluorescence staining when compared 
with the controls in which buffers without enzymes were used (not shown). By 
contrast, nuclear staining by monoclonal antibody against native DNA [10] was 
abolished by DNase pretreatment of cell substrates. Digestion of substrates with 
RNase was also complete. This was shown by loss of nucleolar and cytoplasmic 
staining produced by a monoclonal antibody that binds to ribosomal RNA [14]. 
These data suggested that the antigenicity of7-2-ribonucleoprotein is not depend-
ent on the RNA moiety or DNA but rather located in the protein which is in 
agreement with results obtained by Hashimoto and Steitz [2] who found that 
deproteinized RNA itself is not the target. 
Immunoprecipitation. By screening of a large number of antinucleolar autoim-
mu ne sera, one serum (Wa) precipitated a Mr 40,000 protein from e SS]methio-
nine-Iabeled HeLa cell extract. The 32P-Iabeled immunoprecipitate obtained by 
this serum contained RNA with the mobility as expected for 7-2-RNA but no 
other RNA species (see Fig. 6, lanes 3 and 5). To determine whether serum Wa 
shared the specificity of serum To with regard to its reactivity with 7-2-RNP and 
might be the better antibody for further characterization of the composition of 7-
2-RNP (since lacking 8-2-RNP specificity; see Discussion), we absorbed 
eSS]methionine-labeled HeLa cell extract with the IgG fraction of serum To . 
We then used this absorbed extract in an immunoprecipitation assay and showed 
that this preparation lacked the antigen recognized by antiserum Wa (Fig. 5, lane 
4). Note that antibodies from serum To precipitated a Mr 40,000 protein (arrow in 
lane 3). In a reciprocal fashion , radiolabeled HeLa cell extract, which this time 
had been digested with RNase, was absorbed with IgG from serum Wa and used 
in immunoprecipitation to show that the antigen precipitated by serum To was 
absent in the immunoprecipitate (lane 7). Lanes 2 and 5 show the immunoprecipi-
tates obtained with normal human serum whereas lane J shows 14C-labeled 
molecular weight markers. Figure 6, lane 2 , again shows a Mr 40,000 polypeptide 
(arrowhead) precipitated by antibodies from serum Wa. This protein was not 
• 
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Fig. 3. Electron microscopic localization of7-2-ribonucleoprotein using the preembedding immuno-
gold label technique. Sections of rat liver were incubated with serum To followed by secondary 
antibodies coupled to 5-nm gold particles . IgG from serum To bound to the granular component (GC) 
of the nucleolus. The dense fibrillar component (DFC) and the fibrillar centers (FC) are virtually free 
of gold particles. Ch, chromatin surrounding the nucleolus. Bar 0.2 ~m, x75,000. 
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Fig. 4. Electron microscopic localization of 7-2-ribonucleoprotein using the postembedding 
immuno-gold label technique. Ultrathin frozen sections of paraformaldehyde-fixed HeLa cells were 
incubated with serum To and the immunoreaction was visualized by a second incubation with anti-
human IgG antibodies coupled to 10-nm colloidal gold particles. Gold particles representing anti-
body-antigen complexes are almost exclusively present over the granular component (GC) and virtually 
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Fig . 5. Immunoabsorption experiments. Autoradiogram of e ' S]methionine-labeled immunoprecipi-
tates from HeLa cell extract resolved on a 17.5 % SDS-polyacrylamide gel . Lanes 2 to 4, immunopre-
cipitates from undigested HeLa cell extract, lanes 5 to 7 from RNase-digested extract. Lane 1, 14C_ 
labeled molecular weight markers (overexposed). Lane 2 , proteins precipitated by normal human 
serum. Lane 3 , a Mr 40 ,000 protein (arrow) is additionally precipitated by To antibodies from He La 
cell extract. Lane 4 , proteins immunoprecipitated by antibodies from serum Wa using the antigen 
extract absorbed with To antibodies. Lane 5 , normal human serum. Lane 6, a M, 40,000 protein is 
precipitated by Wa antibodies. Lane 7, immunoprecipitate obtained by To antibodies with the extract 
preabsorbed with Wa antibodies. The M, 40 ,000 protein precipitated by antibodies from serum To 
(lane 3) is not present in lane 7. Note that antibodies from normal human serum and the autoimmune 
sera nonspecifically precipitate a Mr 46 ,000 protein (probably actin). 
precipitated by autoimmune antinucleolar sera with different immunological 
specificities such as anti-RNA polymerase I [5] or anti-PM-Scl [24]. The particle 
precipitated by antibodies from serum Wa contained RNA (Fig. 6, lane 3) with 
the same mobility as that reported for 7-2-RNA associated with the SS-B/La 
ribonucleoprotein [2] (Fig. 6, lane 4). Lane 4 also contains the e2P]orthophos-
phate-labeled pre-5S , pre-tRNA, and a Mr 46,000 phosphoprotein. Lanes 5 and 6 
of this figure display the RNA species of the SS-B/La ribonucleoprotein particle 
after phenol-extraction and ethanol-precipitation side by side with the RNA 
coprecipitated by antibodies from serum Wa after electrophoresis in 7 M urea 8 % 
polyacrylamide gel. Note that only one RNA species with the mobility expected 
for 7-2-RNA was present in the immunoprecipitates of anti-Wa antibodies (lane 5) 
suggesting that serum Wa did not contain antibodies against cytoplasmic 8-2-
ribonucleoprotein or any other ribonucleoprotein. 
Immunoblotting with extractable HeLa cell proteins and isolated He La cell 
nucleoli as antigen source did not identify a Mr 40,000 protein as the anti genic 
target although several weak bands with higher molecular weights were observed 
on prolonged exposure. 
DISCUSSION 
A ribonucleoprotein particle complexed with 7-2-RNA was recently precipitat-
ed by two different autoimmune sera designated anti-To and anti-Th by Reddy et 
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Fig. 6. Immunoprecipitation of [35S]methionine-labeled HeLa cell proteins (lanes I and 2) and 
[ 32p]orthophosphate-labeled He La cell RNA-protein complexes (lanes 3 and 4) with different autoim-
mune sera. Immunoprecipitates were electrophoretically resolved in 17.5 % (lanes I and 2) and 15 % 
(lanes 3 and 4) SOS-polyacrylamide gels. The 32P-labeled immunoprecipitates were also phenolex-
tracted and any RNA was ethanol-precipitated and resolved in 7 M urea 8 % polyacrylamide gels 
(lanes 5 and 6). Lane 1 represents results by normal control serum; lanes 2, 3, and 5 by serum Wa. 
Lanes 4 and 6 show the antigen precipitated by anti-SS-B/La antibodies. Antibodies from serum Wa 
precipitated a Mr 40,000 protein (arrow, lane 2) which was not precipitated by normal human serum 
antibodies (lane I). This M, 40,000 protein did not label with [32P]orthophosphate nor any other 
proteins (lane 3). By contrast, anti-SS-B/La antibodies precipitated a M, 46,000 phosphoprotein 
(arrow) as shown in lane 4. The RNA coprecipitated by antibodies from serum Wa (lanes 3 and 5) has 
the same mobility as the presumptive 7-2-RNA species precipitated by anti-SS-B/La antibodies (lanes 
4 and 6). 
al. [1] and Hashimoto and Steitz [2], respectively. Serum To was from a patient 
with scleroderma and serum Th was from a patient with systemic lupus erythema-
tosus. 7-2-RNA was originally characterized as a nucleolar RNA species in 
biochemical fractionation experiments on rat cells [25] and was shown to be 
among RNA polymerase III transcripts [2]. Antibodies from serum To also 
precipitated a 7-2*-RNA species which had a slightly lower electrophoretic 
mobility on polyacrylamide gels than 7-2-RNA. It was suggested that this differ-
ence in mobility might reflect a few additional nucleotides on the 3' -end of the 7-
2*-RNA molecule [2]. This 7-2*-RNA species appears to be a precursor of 7-2-
RNA and was also shown to be brought down by anti-SS-B/La antibodies [2]. In 
addition to precipitating 7-2-RNA and 7-2*-RNA, antibodies from serum To and 
Th also precipitated cytoplasmic 8-2-RNA. It was clearly shown that bound 
protein was required for antigenicity of both 7-2- and 8-2- ribonucleoprotein [2]. 
The exact molecular composition and biological function of 7-2-ribonucleopro-
tein, however, are unknown. 
In the present study, we showed that autoantibodies against 7-2-RNP immuno-
precipitated at least one protein labeled with e5S]methionine from a HeLa cell 
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extract with mol wt (Mr) of 40,000. No phosphoproteins could be detected in the 
immunoprecipitates using e2P]orthophosphate-labeled HeLa cell extract as anti-
gen source. It is conceivable that the Mr 40,000 protein is the only protein 
associated with 7-2-RNA although additional experimental evidence is needed to 
support this conclusion. Unfortunately, the antibodies did not react unequivocal-
ly with a specific polypeptide band in immunoblots, an observation also made by 
Hashimoto and Steitz [2] in a previous investigation with autoantibodies against 
7-2-RNP. 
The 7-2-ribonucleoprotein was clearly localized in the granular component of 
transcriptionally active nucleoli from rat liver hepatocytes and HeLa cells, as 
shown by preembedding and postembedding immunogold electron microscopy. 
This localization to the granular component of the nucleolus was confirmed by 
immunofluorescence microscopy after segregation of Vero cell nucleoli by the 
drugs actinomycin D and DRB. The staining intensity of the granular component 
of the segregated nucleoli was reduced by drug treatment as compared with 
untreated nucleoli. The reduced staining parallels findings obtained with a novel 
myositis/scleroderma antigen named PM-Scl [24]. The PM-ScI antigen was even 
more sensitive to actinomycin D and DRB than 7-2-RNP, and, therefore, we 
postulated a possible relationship of the PM-ScI antigen with preribosomal parti-
cles. 
The epitopes recognized by antibodies against 7-2-ribonucleoprotein are re-
markably conserved during evolution since the epitopes were present in nucleoli 
of cells from different species. Interestingly, the epitopes of other antinucleolar 
autoantibodies such as anti-RNA polymerase I [5], anti-PM-ScI [24], and anti-
fibrillarin [11] were also shown to be well conserved during evolution suggesting 
that they are basic and important structures of nucleolar proteins. 
There are several nucleolar proteins which have been identified and localized 
in the granular component of the nucleolus. Recently, Hiigle et al. [26] identified 
a nuclear/nucleolar Mr 40,000 protein in Xenopus laevis and other amphibia 
which appears to be specific to precursor particles of the large ribosomal subunit. 
This protein , which was named ribocharin, was specifically mapped to the 
granular component of the nucleolus and nucleoplasmic 65 S particles in amphib-
ia. Ribosomal protein SI , the most acidic protein of the small ribosomal subunit, 
was identified by a monoclonal antibody and localized in the granular component 
of the nucleolus [27] . Another nucleolar protein B23 of rat hepatoma and rat liver 
cells (for review, see Ref. [28]) with a Mr value of 37,000 was also mainly 
localized in the granular component of the nucleolus [29-31]. Protein B23 is 
believed to be associated with ribosomal precursor particles [30]. Whether ribo-
charin and protein B23 are related is not known. Although the present observa-
tions are preliminary, it is of interest to note that the proteins precipitated by 
serum To and serum Wa have a molecular weight similar to those of ribocharin 
and B23. However, an association of the latter two nucleolar proteins with small 
nucleolar RNAs has not been reported so far. It remains unknown whether 
ribocharin or protein B23 are related to 7-2-RNP as detected by human autoanti-
bodies . 
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In situ mapping of nucleolar proteins to defined structural components of 
nucleoli may be important for understanding their function . Autoantibodies reac-
tive with 7-2-ribonucleoprotein clearly localize in the granular component of the 
nucleolus. It is tempting to suggest that 7-2-ribonucleoprotein may be involved in 
the assembly of ribosomal precursor particles, their maturation , and/or transport , 
stages of ribosome biogenesis that have been mapped to the granular component 
of the nucleolus. Further studies are needed to advance this hypothesis and 
antibodies from autoimmune sera such as serum Wa or To could be helpful tools 
in carrying out such investigations. 
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